BioSpace News Archive

Nordic Nanovector ASA announces it will present its results for the third quarter 2018 on Tuesday, 6 November 2018 (previously scheduled for Tuesday, 21 November), and will host a results presentation and webcast on the same day (details will be announced nearer the time).

Genomics England names Congenica as its Clinical Decision Support Service partner for the delivery of the NHS Genomic Medicine Service

CE IVD Mark brings NGS-based clinical test for solid tumors to Europe

ImmunoCellular Therapeutics, Ltd. today announced that on October 16, 2018, the Company received notice from the NYSE American LLC (“NYSE American” or the “Exchange”) that it has determined to commence proceedings to delist the Company’s Common Stock (NYSE American: IMUC) and Listed Common Stock Warrants (NYSE American: IMUC.WS) from the Exchange.

Synpromics is today unveiling its novel drug-regulatable promoter platform at the European Society of Cell and Gene Therapy (ESGCT) congress in Lausanne, Switzerland.

Alkermes plc today announced the presentation of 10 posters at the upcoming 31st Annual Psych Congress (Psych Congress) in Orlando, Oct. 25-28, 2018.

Pursuit Vascular, Inc. today announced it will be showcasing the company’s premier ClearGuard HD cap at two nephrology conferences taking place this month.

Anixa Biosciences presented the results from its ongoing study utilizing Cchek™.

Empowerment Zone Coalition (EZC) will focus on reclaiming youth lost to drugs and alcohol abuse

Volunteer Leaders to Receive Medal of Honor